Attached files

file filename
10-K - 10-K - Phathom Pharmaceuticals, Inc.phat-10k_20201231.htm
EX-32.2 - EX-32.2 - Phathom Pharmaceuticals, Inc.phat-ex322_1449.htm
EX-32.1 - EX-32.1 - Phathom Pharmaceuticals, Inc.phat-ex321_1450.htm
EX-31.2 - EX-31.2 - Phathom Pharmaceuticals, Inc.phat-ex312_1447.htm
EX-31.1 - EX-31.1 - Phathom Pharmaceuticals, Inc.phat-ex311_1411.htm
EX-23.1 - EX-23.1 - Phathom Pharmaceuticals, Inc.phat-ex231_1974.htm
EX-10.22 - EX-10.22 - Phathom Pharmaceuticals, Inc.phat-ex1022_2100.htm
EX-10.21 - EX-10.21 - Phathom Pharmaceuticals, Inc.phat-ex1021_1410.htm
EX-10.20 - EX-10.20 - Phathom Pharmaceuticals, Inc.phat-ex1020_1409.htm
EX-4.6 - EX-4.6 - Phathom Pharmaceuticals, Inc.phat-ex46_8.htm

Exhibit 24.1

LIMITED POWER OF ATTORNEY

 

KNOW ALL PERSONS BY THESE PRESENTS, that each person or entity whose signature appears below constitutes, designates and appoints each of Terrie Curran and Larry Miller, each of whom are officers of Phathom Pharmaceuticals, Inc. (the “Company”), as its true and lawful attorneys-in-fact and agent, each with power of substitution, with full power to act without the other and on behalf of and as attorney for me, for the purpose of executing and filing with the Securities and Exchange Commission the Company’s Annual Report on Form 10-K for the year ended December 31, 2020, and any and all amendments thereto, and to do all such other acts and execute all such other instruments which said attorney may deem necessary or desirable in connection therewith.

 

Signature

Title

Date

 

 

/s/ Michael Cola

Michael Cola

Director

March 10, 2021

 

 

 

/s/ Heidi Kunz

Heidi Kunz

Director

March 11, 2021

 

 

 

/s/ Asit Parikh

Asit Parikh

Director

March 11, 2021

 

 

 

/s/ David Socks

David Socks

Director

March 10, 2021

 

 

 

/s/ Mark Stenhouse

Mark Stenhouse

Director

March 10, 2021

 

 

 

/s/ James Topper

James Topper

Director

March 10, 2021

 

 

 

/s/ Tadataka Yamada

Tadataka Yamada

Director

March 10, 2021